Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
15.29 USD | -2.61% | -5.27% | +1.33% |
05-20 | Entrada Therapeutics Insider Sold Shares Worth $287,695, According to a Recent SEC Filing | MT |
05-16 | Entrada Therapeutics Insider Bought Shares Worth $364,673, According to a Recent SEC Filing | MT |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registrationEPS Revisions
1st Jan change | Capi. | |
---|---|---|
+1.33% | 486M | |
+16.73% | 123B | |
+13.04% | 107B | |
-5.80% | 24.01B | |
+2.50% | 22.59B | |
-10.09% | 18.16B | |
-40.52% | 16.84B | |
-14.00% | 16.23B | |
+1.18% | 13.43B | |
+24.18% | 11.32B |
- Stock Market
- Equities
- TRDA Stock
- News Entrada Therapeutics, Inc.
- Goldman Sachs Adjusts Price Target on Entrada Therapeutics to $18 From $13, Maintains Neutral Rating